McMaster University

About: McMaster University is a education organization based out in Hamilton, Ontario, Canada. It is known for research contribution in the topics: Population & Health care. The organization has 41361 authors who have published 101269 publications receiving 4251422 citations.

Configural Face Processing Develops more Slowly than Featural Face Processing

Abstract: Expertise in face processing takes many years to develop. To determine the contribution of different face-processing skills to this slow development, we altered a single face so as to create sets of faces designed to measure featural, configural, and contour processing. Within each set, faces differed only in the shape of the eyes and mouth (featural set), only in the spacing of the eyes and mouth (spacing set), or only in the shape of the external contour (contour set). We presented adults, and children aged 6, 8, and 10 years, with pairs of upright and inverted faces and instructed them to indicate whether the two faces were the same or different. Adults showed a larger inversion effect for the spacing set than for the featural and external contour sets, confirming that the spacing set taps configural processing. On the spacing set, all groups of children made more errors than adults. In contrast, on the external contour and featural sets, children at all ages were almost as accurate as adults, with no significant difference beginning at age 6 on the external contour set and beginning at age 10 on the featural set. Overall, the results indicate that adult expertise in configural processing is especially slow to develop.

Second-harmonic detection with tunable diode lasers — Comparison of experiment and theory

Abstract: A series of experiments are carried out by current modulating a tunable diode laser, and slowly ramping the wavelength to scan weak absorption lines in gases at pressures ranging from 2 to 60 Torr. A lock-in amplifier detects the second harmonic (2f) of the modulation frequency, and the experimental 2f signals are compared with theory. Detailed measurements are made on Lorentzian, Voigt, and Gaussian line profiles, over a wide range of modulation amplitudes. Excellent agreement between experiment and calculation is obtained in all cases. This quantitative understanding enables one to derive true lineshapes and linewidths of very weak absorption lines from measurements of 2f lineshapes only. Results are applicable to trace gas detection using tunable diode lasers, and to other areas of spectroscopy and magnetic resonance where harmonic detection techniques are routinely employed to monitor weak signals.

Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: The CREATE-ECLA randomized controlled trial

Abstract: Context Glucose-insulin-potassium (GIK) infusion is a widely applicable, low-cost therapy that has been postulated to improve mortality in patients with acute ST-segment elevation myocardial infarction (STEMI). Given the potential global importance of GIK infusion, a large, adequately powered randomized trial is required to determine the effect of GIK on mortality in patients with STEMI. Objective To determine the effect of high-dose GIK infusion on mortality in patients with STEMI. Design, setting, and participants Randomized controlled trial conducted in 470 centers worldwide among 20,201 patients with STEMI who presented within 12 hours of symptom onset. The mean age of patients was 58.6 years, and evidence-based therapies were commonly used. Intervention Patients were randomly assigned to receive GIK intravenous infusion for 24 hours plus usual care (n = 10,091) or to receive usual care alone (controls; n = 10,110). Main outcome measures Mortality, cardiac arrest, cardiogenic shock, and reinfarction at 30 days after randomization. Results At 30 days, 976 control patients (9.7%) and 1004 GIK infusion patients (10.0%) died (hazard ratio [HR], 1.03; 95% confidence interval [CI], 0.95-1.13; P = .45). There were no significant differences in the rates of cardiac arrest (1.5% [151/10 107] in control and 1.4% [139/10,088] in GIK infusion; HR, 0.93; 95% CI, 0.74-1.17; P = .51), cardiogenic shock (6.3% [640/10 107] vs 6.6% [667/10 088]; HR, 1.05; 95% CI, 0.94-1.17; P = .38), or reinfarction (2.4% [246/10,107] vs 2.3% [236/10,088]; HR, 0.98; 95% CI, 0.82-1.17; P = .81). The rates of heart failure at 7 days after randomization were also similar between the groups (16.9% [1711/10,107] vs 17.1% [1721/10,088]; HR, 1.01; 95% CI, 0.95-1.08; P = .72). The lack of benefit of GIK infusion on mortality was consistent in prespecified subgroups, including in those with and without diabetes, in those presenting with and without heart failure, in those presenting early and later after symptom onset, and in those receiving and not receiving reperfusion therapy (thrombolysis or primary percutaneous coronary intervention). Conclusion In this large, international randomized trial, high-dose GIK infusion had a neutral effect on mortality, cardiac arrest, and cardiogenic shock in patients with acute STEMI.